ASAshutosh Shah

Ashutosh Shah

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Ashutosh Shah has a total of 6 co-authors. Here are the top co-authors by number of shared publications:

  • Amita Shah

    Department of Psychiatry, Sir H. N. Reliance Foundation Hospital, Mumbai, Maharashtra, India

    1 shared publication
  • Darshana Rathod

    Department of Critical Care Medicine, Sir H. N. Reliance Foundation Hospital, Mumbai, Maharashtra, India

    1 shared publication
  • Dhiraj Bhattad

    Department of Psychiatry and Internal Medicine, Sir H N Reliance Foundation Hospital, Prathana Samaj, Mumbai, Maharashtra, India

    1 shared publication
  • Mayur Patel

    Department of Critical Care Medicine, Sir H. N. Reliance Foundation Hospital, Mumbai, Maharashtra, India

    1 shared publication
  • Mayur Patel

    Department of Critical Care Medicine, Sir H. N. Reliance Foundation, Mumbai, Maharashtra, India

    1 shared publication
  • Sanket Hansora

    Department of Critical Care Medicine, Sir H. N. Reliance Foundation Hospital, Mumbai, Maharashtra, India

    1 shared publication

Latest Publications

  • Open Access

    Metabolic syndrome in psychiatric disorders

    by Ashutosh Shah

    Individuals suffering from psychiatric disorders are particularly vulnerable to early death, primarily from heart-related reasons. Patients with psychiatric disorders have a higher chance of developing metabolic syndrome. Numerous distinct cardiometabolic risk factors that raise morbidity and mortality are components of metabolic syndrome. There is a bidirectional longitudinal influence with metabolic syndrome and a correlation with the intensity and length of psychiatric symptoms. The development of metabolic syndrome is influenced by a number of factors, including an unhealthy diet, lack of sleep, alcoholism, smoking, genetic polymorphisms, mitochondrial dysfunction, immunometabolic and inflammatory conditions, endocrine abnormalities, and psychiatric medications. The elevated likelihood of metabolic syndrome in psychiatric disorders warrants extreme caution in preventing, closely observing, and managing individuals who are at risk.


  • Open Access

    Delirium-a letter update

    by Ashutosh Shah, Mayur Patel

    Delirium is essentially acute brain failure that results from stressors that surpass the brain's homeostatic reserve. Delirium is caused by a combination of risk factors that are both predisposing and precipitating. Advanced age, frailty, medication exposure or withdrawal, sedation depth, and sepsis are all known risks. Stressors most likely have coordinated rather than independent effects, and the systems they affect are linked rather than separate. Changes in the blood-brain barrier and the central nervous system's de novo synthesis or elaboration of inflammatory mediators account for the pathophysiology of delirium. It also seems that neuro-inflammatory activity contributes to the dysregulation of neurotransmitters.


  • Open Access

    Similar prevalence of anxiety and depression symptoms in any ICU survivor patient relative

    by Ashutosh Shah, Amita Shah, Darshana Rathod, Mayur Patel, Sanket Hansora

    Background: Iwashyna et al defined a chronic critically ill (CCI) patient as any patient requiring care in ICU for more than or equal to 10 days. Physicians often assume that the prevalence of anxiety and depression symptoms in relatives of CCI patients would be higher than in those patients who are not CCI. We hypothesized that there would be no difference in the prevalence of anxiety and depression symptoms of relatives of a CCI and those whose patients are not CCI. We aimed to establish that the prevalence of anxiety and depression symptoms are similar in relatives of any ICU survivor patient. Methods: The study was a non-interventional, observational, cross-sectional study. Relatives were evaluated as early as possible after day ten following ICU admission for CCI patients and non-CCI patients on or a day before discharge from ICU. During this evaluation, anonymous demographic data of relatives were captured, and PHQ-9 and GAD-7 scales were administered and completed by the relative. Results: A total of 418 relatives consented and were included in the study [104 in CCI patient group and 314 in non-CCI group]. Overall, the prevalence of anxiety and depression symptoms in the entire study cohort was 23.2% (95% CI, 19.4-27.5) and 16.5% (95% CI, 13.2-20.4), respectively. There was no statistical difference between the two groups in the proportion of PHQ-9 total score >9 (p value: 0.577) as well as the GAD-7 total score (p value: 0.816). Conclusions: There was no difference in the prevalence of anxiety and depression symptoms in relatives of a CCI versus those whose patients are not CCI.

  • Open Access

    Immediate and short-term prevalence of depression in covid-19 patients and its correlation with continued symptoms experience

    by Ashutosh Shah, Dhiraj Bhattad

    Background: The COVID-19 infection can result in prolonged illness in those infected irrespective of disease severity. Infectious diseases are associated with a higher risk of mood disorders. A better understanding of convalescence, symptom duration, as well as the prevalence of depression among recovering patients, could help plan better care for the survivors of COVID-19. Aim: The study aimed to estimate the immediate and short-term prevalence of major depressive disorder and its correlation with continued symptom experience. Methods: In this non-interventional, observational, and cross-sectional telephone survey study, 273 participants were included from January 2021 to April 2021 and 261 completed follow-up by July 2021. The symptoms at the time of RT-PCR testing and during the two phone calls were captured and the Patient Health Questionnaire 9 item (PHQ-9) version was administered. Results: During the immediate and short-term period following COVID-19, 144/261 (55.1%) and 71/261 (27.2%) patients had not returned to usual health, respectively, and 33/261 (12.8%) and 13/261 (5%) of the patients developed depression, respectively. The binary logistic regression analysis revealed that the independent predictors of depression in short-term period following COVID-19 were comorbid diabetes mellitus (OR = 32.99, 95% CI- 2.19-496, P = 0.011), number of symptoms at the time of RT-PCR testing (OR = 1.89, 95% CI 1.23-1.92, P = 0.018), and number of symptoms at short-term period following COVID-19 (OR = 2.85, 95% CI 1.47-5.51, P = 0.002). Conclusions: Individuals with a greater number of symptoms at the time of RT-PCR testing, with post-COVID symptoms persisting 3 months later, and those who have comorbid diabetes mellitus, are at greater odds to have comorbid depression.